Intra-Cellular Therapies Inc. (ITCI) declined -5.42% or -0.83 to $14.49. It is near to 117282 shares traded, which is 29.31% compare to the average total volume 400115. The market cap of ITCI is $792.98 million. The year to date change is -4.36%. The 52 week price range is from $13.29 to $25.82. Price of ITCI have changed 13.23% during last week. It have changed -14.17% over last month, -29.24% over last 3 months, -29.85% over last 6 months and 3.03% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ITCI is 17.20. It is 18.70% above current price. The 200-day Moving Averages for ITCI is 19.95. It is 37.68% above current price. The 52-week High is 25.82. It is 78.19% from the current price. The 52-week Low is 13.29. It is -8.28% from current price.
There are some statistics of ITCI. It is has market cap $792.98 million. The share outstanding is 54.73 million. The average volume is 400115. The percent of top 15 Institution holding is 119.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ITCI is -42.96%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ITCI is -40.18%.